CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

56 hedge funds and large institutions have $37.3M invested in Carisma Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

0.09% more ownership

Funds ownership: 0.98%1.07% (+0.09%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

54% less call options, than puts

Call options by funds: $80K | Put options by funds: $174K

Holders
56
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$80K
Puts
$174K
Net Calls
Net Calls Change

Top Buyers

1 +$1.61M
2 +$1.21M
3 +$860K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$781K
5
Morgan Stanley
Morgan Stanley
New York
+$592K

Top Sellers

1 -$408K
2 -$274K
3 -$152K
4
Jane Street
Jane Street
New York
-$125K
5
Citadel Advisors
Citadel Advisors
Florida
-$95.7K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$107K
27
$83K
28
$77K
29
$76K
30
$73K
31
$64K
32
$53K
33
$52K
34
$45K
35
$35K
36
$34K
37
$27K
38
$27K
39
$27K
40
$27K
41
$25K
42
$24K
43
$22K
44
$19K
45
$18K
46
$17K
47
$16K
48
$16K
49
$15K
50
$9K